Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2013, Article ID 195456, 15 pages
http://dx.doi.org/10.1155/2013/195456
Review Article

Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?

Department of Anesthesiology, Yale University, New Haven, CT 06520, USA

Received 13 October 2012; Accepted 21 December 2012

Academic Editor: Ping-Yen Liu

Copyright © 2013 Adriana Dana Oprea and Wanda M. Popescu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [5 citations]

The following is the list of published articles that have cited the current article.

  • Max-Paul Winter, Marek Kozinski, Jacek Kubica, Daniel Aradi, and Jolanta M. Siller-Matula, “Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls,” Postepy W Kardiologii Interwencyjnej, vol. 11, no. 4, pp. 259–280, 2015. View at Publisher · View at Google Scholar
  • Mahmoud M.H. Al Omari, Nidal A. Qinna, Iyad S. Rashid, Khaldoun A. Al-Sou'od, and Adnan A. Badwan, “Prasugrel Hydrochloride,” Profiles of Drug Substances, Excipients and Related Methodology, vol. 40, pp. 195–320, 2015. View at Publisher · View at Google Scholar
  • B. A. L. M. Deiman, P. A. L. Tonino, K. Kouhestani, C. E. M. Schrover, V. Scharnhorst, L. R. C. Dekker, and N. H. J. Pijls, “Reduced number of cardiovascular events and increased cost-effectiveness by genotype-guided antiplatelet therapy in patients undergoing percutaneous coronary interventions in the Netherlands,” Netherlands Heart Journal, 2016. View at Publisher · View at Google Scholar
  • Arwa M. Amin, Lim Sheau Chin, Dzul Azri Mohamed Noor, Muhamad Ali SK Abdul Kader, Yuen Kah Hay, and Baharudin Ibrahim, “The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics,” Cardiology Research and Practice, vol. 2017, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Sherry-Ann Brown, and Naveen Pereira, “Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine,” Journal of Personalized Medicine, vol. 8, no. 1, pp. 8, 2018. View at Publisher · View at Google Scholar